U.S. Interactive Media and Services Stock News

Yum China Holdings (YUMC) is back in focus after reporting Q4 and full year 2025 results that highlighted revenue and margin gains, followed by raised 2026 growth expectations and a sizable insider stock sale. See our latest analysis for Yum China Holdings. At a share price of US$54.91, Yum China’s recent 30 day share price return of 11.11% and year to date gain of 13.99% suggest momentum has picked up, even though the 3 year and 5 year total shareholder returns of 7.32% and 3.21% declines...

Capri Holdings has appointed Tyler Reddien as Chief Financial Officer and Chief Operating Officer, effective March 30, 2026, with interim CFO Rajal Mehta returning to his prior role as Michael Kors brand CFO. The consolidation of finance and operations leadership under Reddien, who brings experience from The Body Shop, Natura &Co, Hertz, and United Airlines, could influence how Capri pursues performance improvement and transformation across its global portfolio. Next, we’ll examine how...

Huntington Bancshares has finalized its merger with Cadence Bank, creating a larger regional banking platform. The bank is preparing a major customer account integration that will bring Cadence customers onto Huntington’s systems. The combined bank expands Huntington’s reach in Texas and the Southeast, with operational and customer changes expected as integration progresses. Huntington Bancshares, ticker NasdaqGS:HBAN, is stepping into its next phase as a combined institution after closing...

Naturepedic has entered an exclusive retail partnership with GreenRow, a Williams-Sonoma (NYSE:WSM) brand. The collaboration introduces a dedicated assortment of certified organic sleep products for GreenRow customers. The new Aurora Mattress is debuting as part of the deal, expanding Naturepedic's organic mattress lineup. For Williams-Sonoma, known for premium home and kitchen brands, this move adds more certified organic, healthier sleep options to the GreenRow offering. It aligns with...

If you are wondering whether DigitalOcean Holdings is still attractively priced after its recent run, you are not alone. This article will help you weigh what the current share price really reflects. The stock most recently closed at US$56.06, with returns of 1.5% over the last 30 days, 14.5% year to date, and 30.8% over the past year. The last 7 days showed an 11.9% decline that may have changed how some investors see the risk and reward trade off. Recent news coverage has focused on...

Buenaventura (NYSE:BVN) has approved a higher dividend payout policy, supported by strong operating cash flow. The Board also cleared a higher dividend distribution to shareholders under the new framework. The San Gabriel project is approaching completion, with ramp up reported as close to finished. For you as an investor, the combination of a higher dividend payout policy and a near complete San Gabriel ramp up is a key development for Compañía de Minas Buenaventura, a precious metals...

If you are wondering whether OGE Energy is still fairly priced after its recent run, or if the current share price is giving you a margin of safety, this article walks through what the numbers say about value. With the stock at US$49.14 and returns of 3.8% over 7 days, 12.5% over 30 days, 14.6% year to date, 10.3% over 1 year, 56.3% over 3 years and 93.0% over 5 years, many investors are asking whether the current price still makes sense. Recent attention on OGE Energy has focused on how a...

If you are wondering whether LegalZoom.com’s current share price reflects its true worth, you are not alone. This article focuses on what the numbers say about value. The stock last closed at US$7.03, with a 7 day return of 7.2%, but declines of 20.9% over 30 days, 26.7% year to date, and 30.8% over the past year. These moves have put valuation questions front and center for many investors, who are weighing short term swings against the longer term picture. Evergreen coverage like this aims...

PTC Therapeutics (PTCT) shares are in focus after the company released fourth quarter and full year 2025 results, which combined weaker quarterly figures with a sharp full year swing to positive earnings. See our latest analysis for PTC Therapeutics. At a share price of US$68.19, PTC Therapeutics has recently seen weaker short term share price returns, with a 30 day share price return of 9.72% and a year to date share price return of 11.14%. Its 1 year total shareholder return of 23.4% and 3...

Fulton Financial (FULT) is back on investor radars after a recent share pullback, with the stock closing at US$20.45. That is shifting sentiment toward its valuation and the bank’s underlying financial profile. See our latest analysis for Fulton Financial. The recent 5.5% one day share price decline and 8.7% 7 day share price return dip sit against a 90 day share price return of 11.2% and 1 year total shareholder return of 7.3%. This suggests that longer term momentum is still intact despite...

In recent months, BankUnited reported solid quarterly results and continued investments in digital capabilities and new markets, even as its net interest income growth trailed the broader banking industry and analysts projected a weaker efficiency ratio ahead. This tension between operational expansion and concerns about slowing profitability has led some analysts to question how durable BankUnited’s current growth ambitions may be. Next, we’ll examine how these concerns about slowing net...

Dell Technologies (NYSE:DELL) reported record financial results, supported by a $43b AI server backlog. The company set ambitious AI growth targets and announced a $10b increase to its share repurchase authorization. Dell raised its dividend by 20% and introduced the rugged, liquid cooled PowerEdge XR9700 server for edge AI workloads. The company expanded partnerships, including a deeper alliance with Unisys and an extended collaboration with McLaren Racing in Formula 1. For investors...

Amneal Pharmaceuticals (NasdaqGS:AMRX) reported strong Q4 2025 results, highlighting progress across specialty, injectables, biosimilars, and complex generics. The company announced multiple product launches and regulatory approvals, expanding its presence in higher value segments. Management highlighted a promising pipeline, including biosimilars expected to enter the US market. Amneal also emphasized its collaboration with Pfizer on GLP-1 therapies as a key focus area for future...

If you are wondering whether Home Depot at around US$380 is still a solid entry or starting to look expensive, you are not alone. The stock last closed at US$380.72, with returns of 1.6% over 30 days, 10.1% year to date and 69.6% over 5 years, while the 1 year return is a 1.6% decline and the 3 year return is 37.7%. Recent news coverage has focused on Home Depot's role as a bellwether for US housing and renovation trends, and what that might mean for longer term demand. At the same time,...

Caris Life Sciences (NasdaqGS:CAI) reported an interim readout from its Achieve 1 study for the Caris Detect multi cancer early detection blood test. The interim data show sensitivity and specificity that the company says outperform current methylation based approaches. Caris is adding Whole Transcriptome Sequencing to Caris Detect to deepen molecular resolution in the test. The company also introduced a new AI powered breast cancer signature in its Molecular Tumor Board Report to expand...

Hamilton Insurance Group (HG) is back on investors’ radar after reporting fourth quarter and full year 2025 results, declaring a special dividend of $2.00 per share and attracting renewed attention from Wall Street research desks. See our latest analysis for Hamilton Insurance Group. At a share price of $31.59, Hamilton Insurance Group has seen a 30 day share price return of 13.84% and a year to date share price return of 15.84%. The 1 year total shareholder return of 61.50% points to strong...

Oncolytics Biotech (NasdaqCM:ONCY) has completed patient enrollment in its Phase 1/2 GOBLET study. The company is moving ahead with pivotal trials in squamous cell anal cancer and metastatic colorectal cancer. Management is shifting clinical focus and resources toward these rare cancer indications and planning FDA interactions related to potential approval pathways. Oncolytics Biotech focuses on cancer therapies, and the GOBLET study sits at the center of that effort. With enrollment now...

Daktronics (NasdaqGS:DAKT) has agreed to supply an integrated digital display system across the OCVIBE campus, a large mixed-use development project. The company also announced an executive leadership change, with the former Interim President and CEO moving into an advisory role. Both updates relate to Daktronics' positioning in large commercial installations and its ongoing leadership structure. Daktronics focuses on electronic scoreboards, digital signage, and large-format LED video...

In late February 2026, Pravati Capital announced a partnership with SEI Investments' SEI Access™ marketplace to make litigation finance available as an alternative investment option for registered investment advisors and financial professionals through an end-to-end platform. Around the same time, SEI reported quarterly revenue of US$607.9 million, up 9.1% year on year and slightly above analyst expectations, with management highlighting disciplined execution and broad-based strength across...

Reliance, Inc. (NYSE:RS) raised its quarterly dividend. The company is continuing its long term share buyback program. Both actions reflect management’s current approach to capital allocation and shareholder distributions. Reliance, Inc. (NYSE:RS) operates in the metals service center space, supplying processed metal products to a wide range of end markets. In that kind of business, decisions around dividends and buybacks can matter as much to investors as day to day price moves for steel...

VEON and ride hailing operator Hala have signed a Memorandum of Understanding to expand mobility services in frontier markets. The partnership aims to combine Hala's ride hailing capabilities with VEON's digital platforms and local presence. The agreement builds on VEON's existing mobility offerings and Hala's scale in Dubai to broaden VEON's digital ecosystem beyond telecom. NasdaqGS:VEON currently trades at $55.89, with a return of 24.9% over the past year and a very large gain over three...

If you are wondering whether Turning Point Brands at US$136.99 is priced for perfection or still offers value, you are in the right place. The stock has returned 1.1% over the past week, 13.1% over 30 days, 24.3% year to date and 95.6% over 1 year, while the 3 year return is very large and the 5 year return sits at 195.4%. Recent news coverage has largely focused on Turning Point Brands as a tobacco and related products company operating in a highly regulated industry, with investors paying...

If you have been wondering whether Hormel Foods at around US$25.60 is a bargain or a value trap, you are not alone. This article is built to help you size that up clearly. The stock has recent returns of 2.4% over 7 days, 4.0% over 30 days and 9.4% year to date, while the 1 year, 3 year and 5 year returns of 6.5%, 29.6% and 37.4% declines show a much tougher longer term picture. Recent coverage around Hormel Foods has focused on how a long established packaged food business is responding to...

Texas Roadhouse, Inc. recently reported fourth-quarter and full-year 2025 results showing higher revenue but lower net income year-over-year, while also updating investors on its completed US$120.00 million share repurchase program that retired 701,511 shares. Alongside these results, the Board approved a quarterly cash dividend of US$0.75 per share, payable on March 31, 2026 to shareholders of record on March 17, 2026, underscoring management’s continued emphasis on direct cash returns even...